## Abstract Different mechanisms have been proposed for the failure of interferon (IFN) therapy in patients with chronic hepatitis C and multiple sclerosis, for example, the presence of IFN‐neutralizing antibodies. In this study, a novel assay system based on the IFN‐inducible __Mx__‐promoter was u
Monoclonal antibodies to equine interferon-α (IFN-α): New tools to neutralize IFN-activity and to detect secreted IFN-α
✍ Scribed by Bettina Wagner; Julie M. Hillegas; M. Julia B.F. Flaminio; Eva Wattrang
- Book ID
- 116966063
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 266 KB
- Volume
- 125
- Category
- Article
- ISSN
- 0165-2427
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
CHO cell lines that constitutively produce the murine interferon-alpha (IFN-alpha) subspecies alpha 4 and alpha 6 were constructed. The producer cell lines were protected against viral (vesicular stomatitis virus) infection by the IFN species secreted, but were resistant to the growth inhibitory act
We have established three hybridoma cell lines (designated EBI-1, -2, and -3) secreting immunoglobulin C (IgG) antibodies specific for human alpha-interferon (HulFN-a) by fusing P3X63Ag8.6.5.3 myeloma cells with spleen cells of mice immunized with human "lymphoblastoid" (NC-37) interferon (IFN). The